PILA PHARMA AB acquired TRPV1 antagonists from Ario Pharma Limited.
PILA PHARMA AB completed the acquisition of TRPV1 antagonists from Ario Pharma Limited on March 30, 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.58 SEK | -0.65% |
|
+14.79% | +186.25% |
04-19 | Pila Pharma Appoints New CEO, Chief Scientific Officer | MT |
04-19 | Pila Pharma AB Announces Board and Management Appointments | CI |
1st Jan change | Capi. | |
---|---|---|
+186.25% | 10.43M | |
+54.91% | 815B | |
+44.25% | 654B | |
-6.35% | 354B | |
+21.82% | 337B | |
+10.76% | 302B | |
+18.45% | 247B | |
+2.09% | 229B | |
+13.03% | 219B | |
+8.91% | 171B |